Client, Year

Elixirgen Therapeutics, 
2020

Services

Logo
UX/UI
Website
Illustration

Elixirgen Therapeutics

A brand to keep pace with scientific breakthroughs

Elixirgen develops and delivers therapies for genetic diseases and vaccines. While Ashton was building a brand identity for the biotech firm, their sub-company, Elixirgen Therapeutics, created a breakthrough vaccine for COVID-19.  We collaborated to relaunch their identity and website in just one month to coincide with the company’s press releases.

The identity was inspired by Elixirgen’s mission to cure humanity’s ailments using stem cell biology. San serif and monospace fonts exude a scientific, modern feel. The icon encapsulates the company’s two-track pursuit of immunity + immortality and rejuvenation + regeneration. 

To distinguish Elixirgen Therapeutics from its parent company, we reconfigured the original logo and tweaked its color palette. Custom diagrams and graphics helped explain how the vaccine works.

We then designed and built a website to house the company’s COVID-19 research and breakthroughs.  The urgent nature of the subject matter put the project on an expedited timeline, with all hands on deck.

Aesthetically, the website needed to strike a careful balance between scientific and people-centric to differentiate Elixirgen Therapeutics from other cell therapy labs.

After a month of identity design and iteration, web design, and web development, the website successfully launched on June 3rd, 2020 to coincide with Elixirgen Therapeutics’ COVID-19 vaccine press release.

Stay in Touch

PO Box 50337, Balt., MD 21211

©2024 Ashton Design

Stay in Touch